IonQ (NYSE:IONQ) Trading Up 2.9% – Should You Buy?

IonQ, Inc. (NYSE:IONQ) shares traded up 2.9% during mid-day trading on Monday . The company traded as high as $44.07 and last traded at $43.9130. 22,755,797 shares were traded during mid-day trading, a decline of 6% from the average session volume of 24,270,340 shares. The stock had previously closed at $42.69.

IonQ News Roundup

Here are the key news stories impacting IonQ this week:

• Positive Sentiment: IonQ and Florida LambdaRail agreed to deploy a quantum‑safe network corridor across Florida, moving from trials toward live production use — a concrete commercial customer application that highlights near‑term cybersecurity revenue potential. Florida Quantum Corridor
• Positive Sentiment: IonQ is participating in DARPA’s HARQ program, reinforcing its government / defense credentials and validating its technology with a high‑profile R&D partner — a credibility boost that can support future contract revenue. HARQ Program Involvement
• Positive Sentiment: Revenue momentum remains strong: 2025 revenue grew ~202% to ~$130M and management guided to roughly $225–245M for 2026, indicating rapid top‑line growth that underpins long‑term upside if margins improve. Revenue Growth & Guidance
• Positive Sentiment: Wedbush and other commentators note recent fundamental developments that support a more constructive long‑term view, helping explain the recent momentum into which some investors are now taking profits. Wedbush Commentary
• Neutral Sentiment: Analyst comparisons ahead of Q1 show IonQ with stronger revenue visibility versus some peers (e.g., D‑Wave), which is a positive relative signal but not an outright catalyst by itself. Pre‑Q1 Comparison
• Neutral Sentiment: High recent retail and institutional attention has driven volatility — a reminder that momentum can amplify moves in either direction absent fresh earnings or contract news. Investor Attention
• Negative Sentiment: Shares have pulled back after a big run — articles note daily declines and describe short‑term selling/mean‑reversion as investors lock in gains; IonQ’s high beta amplifies these moves. Daily Decline Coverage
• Negative Sentiment: Despite growth, IonQ remains unprofitable and trades at a rich valuation — some commentary highlights that rivals or industry leaders (favored by big investors) may attract capital away from smaller quantum names. These concerns keep downside risk if execution slips. Competitive/Valuation Concerns

Analyst Ratings Changes

A number of equities analysts have issued reports on the company. Weiss Ratings reaffirmed a “sell (d-)” rating on shares of IonQ in a report on Tuesday, April 21st. Cantor Fitzgerald reaffirmed an “overweight” rating on shares of IonQ in a report on Monday, February 9th. DA Davidson lowered their target price on IonQ from $55.00 to $35.00 and set a “neutral” rating for the company in a report on Thursday, February 26th. Needham & Company LLC lowered their target price on IonQ from $80.00 to $65.00 and set a “buy” rating for the company in a report on Thursday, February 26th. Finally, Benchmark lowered their target price on IonQ from $75.00 to $65.00 and set a “buy” rating for the company in a report on Thursday, February 26th. Ten investment analysts have rated the stock with a Buy rating, six have given a Hold rating and one has assigned a Sell rating to the stock. According to data from MarketBeat, the stock has an average rating of “Moderate Buy” and a consensus target price of $68.25.

IonQ Trading Down 2.3%

The business has a 50-day simple moving average of $35.11 and a 200 day simple moving average of $44.45. The stock has a market cap of $15.43 billion, a P/E ratio of -16.90 and a beta of 2.80.

Insider Buying and Selling at IonQ

In other IonQ news, insider Robert T. Cardillo sold 5,165 shares of the company’s stock in a transaction dated Thursday, February 26th. The stock was sold at an average price of $39.44, for a total value of $203,707.60. Following the sale, the insider owned 112,291 shares in the company, valued at approximately $4,428,757.04. The trade was a 4.40% decrease in their position. The transaction was disclosed in a filing with the SEC, which is accessible through this link. Also, insider John W. Raymond sold 2,800 shares of the company’s stock in a transaction dated Thursday, March 12th. The shares were sold at an average price of $33.34, for a total value of $93,352.00. Following the completion of the sale, the insider owned 83,963 shares in the company, valued at $2,799,326.42. This trade represents a 3.23% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. In the last quarter, insiders have sold 8,581 shares of company stock worth $316,156. Insiders own 5.20% of the company’s stock.

Institutional Investors Weigh In On IonQ

Institutional investors have recently made changes to their positions in the stock. Royal Bank of Canada boosted its position in shares of IonQ by 12.5% during the 1st quarter. Royal Bank of Canada now owns 134,176 shares of the company’s stock valued at $2,962,000 after purchasing an additional 14,898 shares in the last quarter. Amundi bought a new stake in shares of IonQ during the 1st quarter valued at about $630,000. AQR Capital Management LLC boosted its position in shares of IonQ by 106.2% during the 1st quarter. AQR Capital Management LLC now owns 57,305 shares of the company’s stock valued at $1,265,000 after purchasing an additional 29,513 shares in the last quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC boosted its position in shares of IonQ by 24.1% during the 1st quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 450,031 shares of the company’s stock valued at $9,932,000 after purchasing an additional 87,428 shares in the last quarter. Finally, Focus Partners Wealth boosted its position in shares of IonQ by 30.3% during the 1st quarter. Focus Partners Wealth now owns 46,782 shares of the company’s stock valued at $1,032,000 after purchasing an additional 10,881 shares in the last quarter. Institutional investors own 41.42% of the company’s stock.

About IonQ

IonQ, Inc engages in the development of general-purpose quantum computing systems in the United States. It sells access to quantum computers of various qubit capacities. The company makes access to its quantum computers through cloud platforms, such as Amazon Web Services (AWS) Amazon Braket, Microsoft’s Azure Quantum, and Google’s Cloud Marketplace, as well as through its cloud service. It also provides contracts associated with the design, development, and construction of specialized quantum computing hardware systems; maintenance and support services; and consulting services related to co-developing algorithms on quantum computing systems.